コレラワクチンの市場規模、シェア、成長分析、製品タイプ別、投与経路別、エンドユーザー別、年齢層別、流通チャネル別、地域別 - 産業予測、2025-2032年

コレラワクチンの世界市場規模は、2023年に8,020万米ドルと評価され、2024年の8,670万米ドルから2032年には1億6,166万米ドルに成長し、予測期間中（2025-2032年）にCAGR 8.1％で成長する見通しです。

コレラは、汚染された食品や水を介して感染する深刻な細菌感染症であり、重度の下痢、脱水、その他の衰弱症状を特徴とする世界の健康上の重大な脅威となっています。コレラ菌は、数時間から数日で発症し、早急に治療しなければ死に至ることもあります。コレラ発生の主な原因としては、不衛生、不十分な衛生環境、清潔な飲料水へのアクセス不足などが挙げられます。幸いなことに、ワクチン接種が重要な解決策となり、少数の生きたコレラ菌に感染させることで免疫力を高めることができます。静脈内投与、筋肉内投与、経口投与など、さまざまな方法で行われるこのワクチン接種は、世界保健機関（WHO）などの組織が推奨する公衆衛生戦略において重要な役割を果たし、この感染症との闘いに役立っています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

コレラワクチン市場規模：タイプ別

• 市場概要
• 全細胞コレラワクチン（Whole Cell V. Cholerae O1 with Recombinant B- subunit）
• 殺菌経口ワクチン（Killed Oral O1 and O139）

コレラワクチン市場規模：製品別

• 市場概要
• Vaxchora
• Dukoral
• Shanchol
• その他の製品

コレラワクチン市場規模：投与経路別

• 市場概要
• 注射剤ワクチン
• 経口ワクチン

コレラワクチン市場規模：エンドユーザー別

• 市場概要
• 病院
• ホームケア
• 専門クリニック
• その他

コレラワクチン市場規模：年齢層別

• 市場概要
• 大人
• 子供

コレラワクチン市場規模：流通チャネル別

• 市場概要
• 病院薬局
• オンライン薬局
• 小売薬局

コレラワクチン市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Valneva SE（France）
• Sanofi（France）
• Emergent BioSolutions（USA）
• EuBiologics（South Korea）
• Shantha Biotechnics（India）
• Hilleman Laboratories（Singapore）
• Astellas Pharma（Japan）
• Incepta Vaccine（Bangladesh）
• Vabiotech（France）
• Bharat Biotech（India）
• Biological E.（India）
• Serum Institute of India（India）
• Panum Institute（Denmark）
• Walter Reed Army Institute of Research（USA）
• National Institutes of Health（NIH）（USA）
• World Health Organization（WHO）（Switzerland）
• Centers for Disease Control and Prevention（CDC）（USA）
• Medecins Sans Frontieres（MSF）（Switzerland）
• PATH（USA）

結論と提言

Global Cholera Vaccines Market size was valued at USD 80.2 million in 2023 and is poised to grow from USD 86.7 million in 2024 to USD 161.66 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Cholera, a serious bacterial infection transmitted through contaminated food and water, poses a significant global health threat marked by severe diarrhea, dehydration, and other debilitating symptoms. The Vibrio cholera bacterium causes this illness, which can manifest within hours to days, and can be fatal if not treated promptly. Key contributors to cholera outbreaks include poor hygiene, inadequate sanitation, and lack of access to clean drinking water. Fortunately, vaccination offers a vital solution, promoting immunity by exposing individuals to a small number of live cholera bacteria. Administered through various methods including intravenous, intramuscular, or oral routes, cholera vaccines are instrumental in combating this infectious disease, playing a crucial role in public health strategies endorsed by organizations like the World Health Organization.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segments Analysis

Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholera Vaccines Market

The growth of the global cholera vaccines market is primarily driven by innovative approaches in developing new vaccines, heightened awareness surrounding cholera prevention, and the prevalence of unhealthy lifestyle choices, such as inadequate sanitation and consumption of contaminated food. Furthermore, intensified government initiatives and vaccination campaigns have bolstered market expansion. However, the market may face challenges due to stringent FDA regulations and an extended approval timeline for new pharmaceutical products, which can impede the introduction of potentially effective cholera vaccines. Overall, the interplay of these factors shapes the dynamic landscape of the cholera vaccines market on a global scale.

Restraints in the Global Cholera Vaccines Market

One of the major factors hindering the growth of the global cholera vaccines market is the prolonged time required for vaccine development, coupled with the stringent regulatory approval processes in place. These challenges can create delays in bringing new vaccines to market, which may ultimately impact the availability of effective cholera prevention methods. As a result, these factors can constrain the overall expansion and accessibility of cholera vaccines, especially in regions where the disease is prevalent. Consequently, addressing these hurdles is crucial for enhancing the market's growth trajectory and improving public health outcomes related to cholera.

Market Trends of the Global Cholera Vaccines Market

The global cholera vaccines market is experiencing a significant upward trend, propelled by the alarming rise in cholera cases linked to inadequate sanitation and hygiene, particularly in rural and remote regions. As cholera outbreaks become more prevalent, public health initiatives and governmental support are heightening awareness about the critical role of vaccination in combatting this preventable disease. The increasing focus on disease prevention, coupled with advancements in vaccine technology and distribution strategies, is further driving demand. Moreover, collaborative efforts between organizations and health authorities to enhance accessibility underpin a promising growth trajectory for the cholera vaccines market in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholera Vaccines Market Size by Type & CAGR (2025-2032)

• Market Overview
• Whole Cell V. Cholerae O1 with Recombinant B- subunit
• Killed Oral O1 and O139

Global Cholera Vaccines Market Size by Product & CAGR (2025-2032)

• Market Overview
• Vaxchora
• Dukoral
• Shanchol
• Other Products

Global Cholera Vaccines Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Injectables Vaccines
• Oral Vaccines

Global Cholera Vaccines Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cholera Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults
• Children

Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cholera Vaccines Market Size & CAGR (2025-2032)

• North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuBiologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantha Biotechnics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hilleman Laboratories (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Vaccine (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vabiotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panum Institute (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walter Reed Army Institute of Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Institutes of Health (NIH) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Health Organization (WHO) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centers for Disease Control and Prevention (CDC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medecins Sans Frontieres (MSF) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PATH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations